Tampa, FL, January 6, 2023 -- McapMediaWire -- RemSleep Holdings Inc. (OTCQB: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients, today provides a corporate update and letter to shareholders from CEO Tom Wood. Dear RemSleep Shareholders, 2023 is shaping up to be an extremely pivotal year for RemSleep and I couldn’t be more excited for the Company due to how we are currently positioned going into the New Year....

Tampa, FL, November 08, 2022 -- McapMediaWire -- RemSleep Holdings Inc. (OTCQB: RMSL), a medical device manufacturer dedicated to forever improving the level of treatment provided to obstructive Sleep Apnea patients, is pleased to announce that the expected last battery of testing will commence this week for final FDA submission of the company’s signature DeltaWave mask. The series of additional tests that were identified in the prior GXP analysis are expected to take approximately 14-18...

    Tampa, FL, July 27, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever improving the level of treatment provided to obstructive Sleep Apnea patients, is pleased to announce that the company’s common shares will begin trading on the OTCQB Market as of the opening of the market on today, July 27, 2022. The OTCQB is the premiere marketplace for entrepreneurial and development stage U.S. and international companies that...

  Tampa, FL, July 22, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever improving the level of treatment provided to obstructive Sleep Apnea patients, announces the company has formally retained a new Senior Director for Regulatory Compliance and Regulatory submissions to gain FDA clearance to market the company’s medical device respiratory products. In addition, a new Regulatory Testing Company has been engaged.  Both will...

  Tampa, FL, July 19, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive Sleep Apnea patients, provides today, an update to the Company’s press release entitled, “RemSleep Holdings Inc. Announces Acceptance and Approval of the Company’s OTCQB Application” which was issued on July 12th, 2022. In said press release, RemSleep stated, “…announced today that the company has...

  Tampa, FL, July 12, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive Sleep Apnea patients, announced today that the company has officially received approval to be uplisted to OTCQB® status with otcmarkets.com. We anticipate OTCQB® status to be live on otcmarkets.com within 24-48 hours of this press release. The move to the OTCQB® exchange provides enhanced investor...

  Tampa, FL, June 16, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients, would like to address shareholders regarding the S-1 filing from June 15th, 2022. First and foremost, we want to be clear, we did not file the S-1 out of necessity. This was set up as a precautionary safety net given the current global and U.S. economic dynamics, and the...

  Tampa, FL, June 10, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients, today announced that the company has officially filed its application for OTCQB® status with otcmarkets.com. The company anticipates receiving a decision on the application in approximately 3-4 weeks. The Company believes that the move to the OTCQB® will provide enhanced...

  Tampa, FL, June 06, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients, today provides a corporate update and letter from CEO Tom Wood. Dear Shareholders, On Friday the 27th of May, we were informed by the FDA after months of waiting, the DeltaWave will be reclassified under 510K review as an implantable device. Consequently, additional testing is...

  Tampa, FL, May 6, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients, today announced that the company has responded to the Additional Information request pertaining to their current 510(k) application to the U.S. Food and Drug Administration (FDA) for its patented DeltaWave device, a nasal mask CPAP interface. https://youtu.be/6Dtl4485Yn8 “This...